MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma
- 1 February 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (2), 245-254
- https://doi.org/10.1038/s41379-019-0310-0
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant MesotheliomasArchives Of Pathology & Laboratory Medicine, 2018
- Malignant mesothelioma in situHistopathology, 2018
- A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesotheliomaCancer Cytopathology, 2018
- Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesotheliomaAnnals of Diagnostic Pathology, 2017
- What is your diagnosis? Bicavitary effusion in a horseVeterinary Clinical Pathology, 2017
- Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survivalClinical Epidemiology, 2016
- Loss of expression of BAP1 is very rare in non-small cell lung carcinomaPathology, 2016
- Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesotheliomaHuman Pathology, 2016
- Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology SpecimensThe American Journal of Surgical Pathology, 2016
- The evolving role of effusion cytology in the diagnosis of malignant mesotheliomaCytopathology, 2015